Developing Growth Fund
Daily price w/o sales charge as of 01/21/2021
$43.46
$0.17
YTD Returns w/o sales charge as of 01/21/2021
10.53%
Overall Morningstar RatingsSmall Growth
as of 12/31/2020
Morningstar rated the Lord Abbett Developing Growth Fund class R6 share 5 and 5 stars among 576 and 505 Small Growth Funds for the overall rating and the 3 and 5 year periods ended 12/31/2020, respectively.
Please click here for performance current to the most recent quarter-end and month-end.
Summary
Summary
The Fund seeks to deliver long-term growth of capital by investing primarily in stocks of small U.S. companies.
Fund Basicsas of 12/31/2020
- Total Net Assets
- $4.40 B
- Inception Date
- 06/30/2015
- Dividend Frequency
- Annually
- Fund Expense Ratio
- 0.60%
- Number of Holdings
- 102
Fund Expense Ratio :
0.60%
| YTD | 1-YR | 3-YR | 5-YR | 10-YR | Since Inception |
|---|
| w/o sales charge | 73.11% | 73.11% | 34.19% | 25.21% | 17.59% | - |
| Lipper Category Avg. Small-Cap Growth Funds | 38.35% | 38.35% | 18.76% | 17.68% | 13.52% | - |
| Russell 2000® Growth Index | 34.63% | 34.63% | 16.20% | 16.36% | 13.48% | - |
Fund Expense Ratio :
0.60%
Fund Expense Ratio :
0.60%
| YTD | 1-YR | 3-YR | 5-YR | 10-YR | Since Inception |
|---|
| w/o sales charge | 73.11% | 73.11% | 34.19% | 25.21% | 17.59% | - |
| Lipper Category Avg. Small-Cap Growth Funds | 38.35% | 38.35% | 18.76% | 17.68% | 13.52% | - |
| Russell 2000® Growth Index | 34.63% | 34.63% | 16.20% | 16.36% | 13.48% | - |
Fund Expense Ratio :
0.60%
The performance quoted represents past performance, which is no indication of future results. Current performance may be higher or lower than the performance data quoted. Returns shown include the reinvestment of all distributions. Returns shown at net asset value do not reflect the current maximum sales charge, had the sales charge been included, returns would have been lower. The investment return and principal value of an investment will fluctuate so that shares, on any given day or when redeemed, may be worth more or less than the original cost. Therefore, there can be no assurance for future results.
TEN LARGEST HOLDINGS as of 12/31/2020View Portfolio
| Holding | Assets |
|---|---|
| Appian Corp | 1.9% |
| Inspire Medical Systems Inc | 1.9% |
| Shift4 Payments Inc | 1.9% |
| Cardlytics Inc | 1.8% |
| Natera, Inc. | 1.7% |
| TG Therapeutics, Inc. | 1.7% |
| Five9, Inc. | 1.6% |
| MKS Instruments, Inc. | 1.5% |
| Redfin Corp | 1.5% |
| Restoration Hardware Holdings, Inc. | 1.5% |
Aggregate holdings are updated monthly, 30 days after month end. Aggregate holdings are presented to illustrate examples of the securities that the Fund has bought and the diversity of the areas in which the Fund may invest, and may not be representative of the Fund's current or future investments. The figures presented are as of the date shown and may change at any time.
Sector Allocationas of 12/31/2020View Portfolio
| Sector | Weighting |
|---|
| Sector | Weighting |
|---|---|
| Communication Services | |
| Real Estate | |
| Utilities | |
| Not Classified | |
| Consumer Discretionary | |
| Consumer Staples | |
| Energy | |
| Financials | |
| Health Care | |
| Industrials | |
| Information Technology | |
| Materials |
INVESTMENT TEAM
Your Representative
To contact your representative, enter your zip code and select your channel below.
Performance
Performance
Fund Expense Ratio :
0.60%
| YTD | 1-YR | 3-YR | 5-YR | 10-YR | Since Inception |
|---|
| w/o sales charge | 73.11% | 73.11% | 34.19% | 25.21% | 17.59% | - |
| Lipper Category Avg. Small-Cap Growth Funds | 38.35% | 38.35% | 18.76% | 17.68% | 13.52% | - |
| Russell 2000® Growth Index | 34.63% | 34.63% | 16.20% | 16.36% | 13.48% | - |
Fund Expense Ratio :
0.60%
Fund Expense Ratio :
0.60%
| YTD | 1-YR | 3-YR | 5-YR | 10-YR | Since Inception |
|---|
| w/o sales charge | 73.11% | 73.11% | 34.19% | 25.21% | 17.59% | - |
| Lipper Category Avg. Small-Cap Growth Funds | 38.35% | 38.35% | 18.76% | 17.68% | 13.52% | - |
| Russell 2000® Growth Index | 34.63% | 34.63% | 16.20% | 16.36% | 13.48% | - |
Fund Expense Ratio :
0.60%
The performance quoted represents past performance, which is no indication of future results. Current performance may be higher or lower than the performance data quoted. Returns shown include the reinvestment of all distributions. Returns shown at net asset value do not reflect the current maximum sales charge, had the sales charge been included, returns would have been lower. The investment return and principal value of an investment will fluctuate so that shares, on any given day or when redeemed, may be worth more or less than the original cost. Therefore, there can be no assurance for future results.
| Year | Fund Returns | Russell 2000® Growth Index |
|---|
| 2020 | 73.11% | 34.63% |
| 2019 | 32.40% | 28.48% |
| 2018 | 5.42% | -9.31% |
| 2017 | 30.39% | 22.17% |
| 2016 | -2.33% | 11.32% |
| 2015 | -8.49% | -1.38% |
| 2014 | 3.70% | 5.60% |
| 2013 | 57.99% | 43.30% |
| 2012 | 10.88% | 14.59% |
| 2011 | -1.16% | -2.91% |
| 2010 | 37.21% | - |
| 2009 | 47.74% | - |
| 2008 | -47.24% | - |
| 2007 | 36.48% | - |
| 2006 | 13.02% | - |
| 2005 | 12.47% | - |
| 2004 | 6.54% | - |
| Year | Q1 | Q2 | Q3 | Q4 | Yearly Returns |
|---|
| 2021 | - | - | - | - | 10.53% |
| 2020 | -16.85% | 40.72% | 16.00% | 27.54% | 73.11% |
| 2019 | 27.13% | 9.20% | -11.28% | 7.50% | 32.40% |
| 2018 | 7.25% | 15.05% | 12.26% | -23.89% | 5.42% |
| 2017 | 8.48% | 4.13% | 7.16% | 7.73% | 30.39% |
| 2016 | -10.23% | 2.33% | 10.98% | -4.20% | -2.33% |
| 2015 | 7.22% | 2.73% | -15.60% | -1.57% | -8.49% |
| 2014 | 1.80% | 0.28% | -5.68% | 7.70% | 3.70% |
| 2013 | 13.64% | 10.16% | 18.92% | 6.12% | 57.99% |
| 2012 | 12.28% | -2.56% | 5.70% | -4.12% | 10.88% |
| 2011 | 10.36% | 1.64% | -20.75% | 11.20% | -1.16% |
| 2010 | 8.29% | -7.81% | 16.65% | 17.83% | 37.21% |
| 2009 | -2.02% | 24.54% | 14.28% | 5.95% | 47.74% |
| 2008 | -21.72% | 6.73% | -11.66% | -28.51% | -47.24% |
| 2007 | 4.79% | 13.71% | 10.00% | 4.13% | 36.48% |
| 2006 | 16.11% | -6.10% | -6.71% | 11.12% | 13.02% |
| 2005 | -5.73% | 5.89% | 9.75% | 2.66% | 12.47% |
| 2004 | - | - | - | 11.67% | 6.54% |
Performance is shown for each quarter and each calendar year. Past performance is no guarantee of future results.
NAV Historical Prices
| Date | Net Asset Value |
|---|
Portfolio
Portfolio
| Holding | Sector | Assets |
|---|
| Appian Corp | Information Technology | 1.9% |
| Inspire Medical Systems Inc | Health Care | 1.9% |
| Shift4 Payments Inc | Information Technology | 1.9% |
| Cardlytics Inc | Information Technology | 1.8% |
| Natera, Inc. | Health Care | 1.7% |
| TG Therapeutics, Inc. | Health Care | 1.7% |
| Five9, Inc. | Information Technology | 1.6% |
| MKS Instruments, Inc. | Information Technology | 1.5% |
| Redfin Corp | Real Estate | 1.5% |
| Restoration Hardware Holdings, Inc. | Consumer Discretionary | 1.5% |
Aggregate holdings are updated monthly, 30 days after month end. Aggregate holdings are presented to illustrate examples of the securities that the Fund has bought and the diversity of the areas in which the Fund may invest, and may not be representative of the Fund's current or future investments. The figures presented are as of the date shown and may change at any time.
| Holding | Sector | Assets |
|---|
| Inspire Medical Systems Inc | Health Care | 2.2% |
| Appian Corp | Information Technology | 1.9% |
| Restoration Hardware Holdings, Inc. | Consumer Discretionary | 1.7% |
| Natera, Inc. | Health Care | 1.7% |
| Cardlytics Inc | Information Technology | 1.7% |
| Axon Enterprise, Inc. | Industrials | 1.6% |
| Five9, Inc. | Information Technology | 1.6% |
| Paylocity Holding Corp. | Information Technology | 1.6% |
| MKS Instruments, Inc. | Information Technology | 1.6% |
| Sunrun, Inc. | Industrials | 1.5% |
| iRhythm Technologies, Inc. | Health Care | 1.5% |
| Insmed, Inc. | Health Care | 1.5% |
| Repligen Corp. | Health Care | 1.4% |
| LGI Homes, Inc. | Consumer Discretionary | 1.4% |
| Shift4 Payments Inc | Information Technology | 1.4% |
| Evoqua Water Technologies Corp | Industrials | 1.4% |
| Crocs, Inc. | Consumer Discretionary | 1.3% |
| Semtech Corp. | Information Technology | 1.3% |
| Mirati Therapeutics, Inc. | Health Care | 1.3% |
| National Vision Holdings Inc | Consumer Discretionary | 1.3% |
| Blueprint Medicines Corp. | Health Care | 1.3% |
| Chart Industries, Inc. | Industrials | 1.3% |
| Helen of Troy Ltd. | Consumer Discretionary | 1.3% |
| Deckers Outdoor Corp. | Consumer Discretionary | 1.3% |
| Goosehead Insurance Inc | Financials | 1.3% |
| Generac Holdings, Inc. | Industrials | 1.3% |
| Inphi Corp. | Information Technology | 1.3% |
| Enphase Energy, Inc. | Information Technology | 1.3% |
| Penn National Gaming, Inc. | Consumer Discretionary | 1.2% |
| YETI Holdings Inc | Consumer Discretionary | 1.2% |
| Blackline, Inc. | Information Technology | 1.2% |
| Nevro Corp. | Health Care | 1.2% |
| Digital Turbine Inc | Information Technology | 1.2% |
| Q2 Holdings, Inc. | Information Technology | 1.2% |
| Bridgebio Pharma Inc | Health Care | 1.2% |
| Redfin Corp | Real Estate | 1.2% |
| Wingstop, Inc. | Consumer Discretionary | 1.2% |
| Malibu Boats, Inc. | Consumer Discretionary | 1.2% |
| Turning Point Therapeutics Inc | Health Care | 1.1% |
| Axonics Modulation Technologies Inc | Health Care | 1.1% |
| Endava PLC | Information Technology | 1.1% |
| Globant SA | Information Technology | 1.1% |
| Boston Beer Co., Inc. | Consumer Staples | 1.1% |
| Acceleron Pharma, Inc. | Health Care | 1.0% |
| SVMK Inc | Information Technology | 1.0% |
| Fiverr International Ltd | Consumer Discretionary | 1.0% |
| Diodes, Inc. | Information Technology | 1.0% |
| TG Therapeutics, Inc. | Health Care | 1.0% |
| Sprout Social Inc | Information Technology | 1.0% |
| Twist Bioscience Corp | Health Care | 1.0% |
| Freshpet, Inc. | Consumer Staples | 1.0% |
| Monolithic Power Systems, Inc. | Information Technology | 0.9% |
| Invitae Corp | Health Care | 0.9% |
| Lumentum Holdings, Inc. | Information Technology | 0.9% |
| CRISPR Therapeutics AG | Health Care | 0.9% |
| Iovance Biotherapeutics Inc | Health Care | 0.8% |
| Avalara Inc | Information Technology | 0.8% |
| Planet Fitness, Inc. | Consumer Discretionary | 0.8% |
| Arena Pharmaceuticals, Inc. | Health Care | 0.8% |
| Penumbra, Inc. | Health Care | 0.8% |
| CareDx Inc | Health Care | 0.8% |
| Everbridge, Inc. | Information Technology | 0.8% |
| Littelfuse, Inc. | Information Technology | 0.8% |
| CEVA, Inc. | Information Technology | 0.7% |
| Altra Holdings, Inc. | Industrials | 0.7% |
| XPO Logistics, Inc. | Industrials | 0.7% |
| Stamps.com, Inc. | Consumer Discretionary | 0.7% |
| Berkeley Lights Inc | Health Care | 0.7% |
| Adaptive Biotechnologies Corp | Health Care | 0.7% |
| Trex Co., Inc. | Industrials | 0.7% |
| Myovant Sciences Ltd | Health Care | 0.7% |
| AZEK Co Inc/The | Industrials | 0.7% |
| Calix Networks, Inc. | Information Technology | 0.7% |
| Guardant Health Inc | Health Care | 0.7% |
| Tandem Diabetes Care, Inc. | Health Care | 0.6% |
| Balchem Corp. | Materials | 0.6% |
| Jamf Holding Corp | Information Technology | 0.6% |
| Cerence Inc | Information Technology | 0.6% |
| Seres Therapeutics, Inc. | Health Care | 0.6% |
| ChemoCentryx Inc | Health Care | 0.6% |
| Brooks Automation Inc | Information Technology | 0.6% |
| Flying Eagle Acquisition Corp | Undefined | 0.6% |
| Federal Signal Corp. | Industrials | 0.6% |
| Schrodinger Inc/United States | Health Care | 0.5% |
| Rocket Pharmaceuticals Inc | Health Care | 0.5% |
| Pacific Biosciences of California, Inc. | Health Care | 0.5% |
| LiveRamp Holdings Inc | Information Technology | 0.5% |
| Trupanion Inc | Financials | 0.5% |
| Grocery Outlet Holding Corp | Consumer Staples | 0.5% |
| Inari Medical Inc | Health Care | 0.5% |
| Shockwave Medical Inc | Health Care | 0.5% |
| Upwork Inc | Industrials | 0.5% |
| Deciphera Pharmaceuticals Inc | Health Care | 0.5% |
| Western Alliance Bancorp | Financials | 0.5% |
| Karuna Therapeutics Inc | Health Care | 0.4% |
| Constellation Pharmaceuticals Inc | Health Care | 0.4% |
| Rapid7, Inc. | Information Technology | 0.4% |
| Yext Inc | Information Technology | 0.4% |
| Lemonade Inc | Financials | 0.3% |
| Datto Holding Corp | Information Technology | 0.3% |
| Relay Therapeutics Inc | Health Care | 0.3% |
| Silk Road Medical Inc | Health Care | 0.2% |
Aggregate holdings are updated monthly, 30 days after month end. Aggregate holdings are presented to illustrate examples of the securities that the Fund has bought and the diversity of the areas in which the Fund may invest, and may not be representative of the Fund's current or future investments. The figures presented are as of the date shown and may change at any time.
Sector Allocationas of 12/31/2020
| Sector | Weighting | Fund Change from Previous Quarter |
|---|
| Sector | Weighting | Fund Change from Previous Quarter |
|---|---|---|
| Communication Services |
 0.9%
|
|
| Real Estate |
0.9%
|
|
| Utilities | 0.0% | |
| Not Classified |
0.8%
|
|
| Consumer Discretionary |
3.2%
|
|
| Consumer Staples |
1.1%
|
|
| Energy | 0.0% | |
| Financials |
1.5%
|
|
| Health Care |
1.6%
|
|
| Industrials |
1.5%
|
|
| Information Technology |
4.2%
|
|
| Materials |
0.6%
|
Portfolio Details as of 12/31/2020
- Total Net Assets
- $4.40 B
- Number of Holdings
- 102
- Weighted Average Market Cap.
- 6.5 B
- P/B Ratio
- 8.7x
- Portfolio Turnover Ratio as of 07/31/2020
- 121.6%
- P/E Ratio
- 45.3x
To view definitions for the above Portfolio Details, Click here.
Market Capitalization Breakdown - Morningstar separates stock portfolio holdings into five market-capitalization groups: Giant, Large, Mid, Small, and Micro. Of the 5000 largest domestic stocks in their equities database, the top 1% are categorized as Giant, the next 4% are Large, the next 15% are Mid, the next 30% are Small, and the remaining 50% are Micro. Stocks outside of the largest 5000 are also classified as Micro.
Weighted Average Market Cap - The average market capitalization of all companies held in the portfolio with each company weighted according to its percent held in the portfolio. The result is based upon a weighted average of the securities held in the fund.
P/B Ratio - A ratio that helps determine whether a stock is undervalued or overvalued. It is calculated by dividing a stock's price per share by its book value per share. The result is based upon a weighted average of the securities held in the fund.
P/E Ratio - Is the weighted average of each holding's P/E ratio (price of a stock divided by its earnings per share). The result is based upon a weighted average of the securities held in the fund.
Portfolio Turnover - This is a measure of the Fund’s trading activity which is computed by taking the lesser of purchases or sales divided by average monthly market value, excluding short-term investments. The resulting percentage represents the percentage of the portfolio’s holdings that have changed over the past year.
Contributors & Detractors as of 12/31/2020
Contributors
| Holding | Contribution |
|---|---|
| Appian Corp | 1.6% |
| Cardlytics Inc | 1.0% |
| Enphase Energy, Inc. | 1.0% |
| TG Therapeutics, Inc. | 0.9% |
| Bridgebio Pharma Inc | 0.8% |
Detractors
| Holding | Contribution |
|---|---|
| Overstock.com, Inc. | -0.3% |
| Stamps.com, Inc. | -0.3% |
| Seres Therapeutics, Inc. | -0.2% |
| Tandem Diabetes Care, Inc. | -0.2% |
| Limelight Networks, Inc. | -0.2% |
% Contribution reflects the effect of the individual stock's performance on the Fund's overall performance for the period. Individual holdings and their effect on Fund performance may change significantly over time. Investors should consider the overall performance of the Fund before making a decision on whether or not to invest in the Fund.
Attribution Analysis
| Developing Growth Fund | Benchmark | Variance | |||||
|---|---|---|---|---|---|---|---|
| Sector | Avg. Weight | Base Return | Avg. Weight | Base Return | Stock Selection | Group Weight | Total |
The total base return displayed for the Fund does not capture daily cash flow and trading activity and therefore is subject to reasonable variance from the Fund's actual return. Please refer to the Fund's performance results for longer-term returns. The Fund is actively managed and portfolio characteristics, such as individual holdings and sector weightings, may change significantly over time.
Source: Wilshire Attribution Software. GICS sector classification; non-GICS securities classified by Lord Abbett. Sectors may include many industries.
Dividends & Cap Gains
Dividends & Cap Gains
Upcoming Dividend Payment Dates
This section lists all anticipated Income and Capital Gain distribution dates and any actual distributions are subject to adequacy of earnings and must be approved by the Board of Directors/Trustees. Please note that dates are subject to change.
| Record Date | Ex-Dividend Date | Reinvest & Payable Date |
|---|---|---|
| 11/22/2021 | 11/23/2021 | 11/23/2021 |
Capital Gains Distributions
| Record Date | Reinvest & Payable Date | Long-term | Short-term * | Total | Reinvest Price |
|---|---|---|---|---|---|
| 11/23/2020 | 11/24/2020 | $2.1959 | $0.7588 | $2.9547 | $35.02 |
Taxed as ordinary income
Lord Abbett does not provide tax advice. It is strongly recommended that you discuss the impact of dividends and distributions with your tax advisor.
Upcoming Capital Gain Distribution
This section lists all anticipated Income and Capital Gain distribution dates and any actual distributions are subject to adequacy of earnings and must be approved by the Board of Directors/Trustees. Please note that dates are subject to change.
| Record Date | Ex-Dividend Date |
|---|---|
| 11/22/2021 | 11/23/2021 |
Fees & Expenses
Fees & Expenses
Expense Ratioas of 12/31/2020
| 0.60% |
Fund Documents
Fund Documents
Download fund documents & literature, create email subscriptions, and place direct mail order
|
0Documents selected
|
Order | ||||
|---|---|---|---|---|---|
| n/a |
Portfolio Holdings 1Q
Publish Date:11/03/2015
|
||||
| n/a |
Portfolio Holdings 3Q
Publish Date:11/03/2015
|
||||
|
Summary Prospectus
Publish Date:11/03/2015
|
|||||
| n/a |
Statutory Prospectus
Publish Date:11/03/2015
|
||||
| n/a |
Prospectus (XBRL)
Publish Date:11/03/2015
|
||||
|
SAI
Publish Date:11/03/2015
|
|||||
|
Annual Report
Publish Date:11/03/2015
|
|||||
|
Semi-Annual Report
Publish Date:11/03/2015
|
|||||
|
Fact Sheet
Publish Date:11/03/2015
|
|||||
|
Commentary
Publish Date:11/03/2015
|
|||||
|
Fund Story
Publish Date:11/03/2015
|
|||||